---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-408289"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2026-09-30T11:15:20+00:00"
generated_at: "2026-10-12T13:57:16.583053+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Moderna names Juan Andres as first COO effective Oct 5; Jerh Collins to retire

## Summary
- Juan Andres returns to Moderna as Chief Operating Officer, effective October 5, 2026, reporting to CEO Stephane Bancel and serving on the Executive Committee.
- Andres' pay: $800,000 base salary, 90% annual bonus target, $5,000,000 new-hire equity award vesting over four years (max 75% in RSUs).
- Future annual equity award target set at $4,000,000-$5,000,000, subject to Compensation Committee approval.
- Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer since January 2023, is retiring; he joined Moderna in October 2022 after nearly 30 years at Novartis.
- Company cites preparation for potential launch of intismeran autogene after positive Phase 3 results; the therapy is co-developed with Merck (MSD).

## SEC filing metadata
- accession: 0001193125-26-408289
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2026-09-30T11:15:20+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000119312526408289/0001193125-26-408289-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000119312526408289/d18337d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-408289
- JSON: https://secwatch.observer/filing/0001193125-26-408289.json
- Plain text: https://secwatch.observer/filing/0001193125-26-408289.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.